HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism

Amy P. Chiu; Barbara R. Tschida; Tung Ting Sham; Lilian H. Lo; Branden S. Moriarity; Xiao Xiao Li; Regina C. Lo; David E. Hinton; Dewi K. Rowlands; Chi On Chan; Daniel K.W. Mok; David A. Largaespada; Nadia Warner; Vincent W. Keng

doi:10.1158/1541-7786.MCR-18-1127

HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism

Amy P. Chiu, Barbara R. Tschida, Tung Ting Sham, Lilian H. Lo, Branden S. Moriarity, Xiao Xiao Li, Regina C. Lo, David E. Hinton, Dewi K. Rowlands, Chi On Chan, Daniel K.W. Mok, David A. Largaespada, Nadia Warner, Vincent W. Keng (Corresponding Author)

Research output: Journal article publication › Journal article › Academic research › peer-review

16 Citations (Scopus)

Abstract

Chronic hepatitis B viral (HBV) infection remains a high underlying cause for hepatocellular carcinoma (HCC) worldwide, while the genetic mechanisms behind this remain unclear. This study elucidated the mechanisms contributing to tumor development induced by the HBV X (HBx) gene of predominantly Asian genotype B HBV and its common HBx variants. To compare the potential tumorigenic effects of K130M/V131I (Mut) and wild-type (WT) HBx on HCC, the Sleeping Beauty (SB) transposon system was used to deliver HBx Mut and WT into the livers of fumarylacetoacetate hydrolase (Fah)-deficient mice and in the context of transformation related protein 53 (Trp53) deficiency. From our results, HBx Mut had a stronger tumorigenic effect than its WT variant. Also, inflammation, necrosis, and fibrosis were evident in HBx experimental animals. Reduction of forkhead box O1 (FOXO1) with increased phosphorylation of upstream serine/ threonine kinase (AKT) was detected under HBx Mut overexpression. Thus, it is proposed that HBx Mut enhances disease progression by reducing FOXO1 via phosphorylation of AKT. At the metabolomic level, HBx altered the expression of genes that participated in arachidonic acid (AA) metabolism, as a result of inflammation via accumulation of proinflammatory factors such as prostaglandins and leukotriene in liver. Taken together, the increased rate of HCC observed in chronic hepatitis B patients with K130M/V131I-mutated X protein, may be due to changes in AA metabolism and AKT/ FOXO1 signaling.

Original language	English
Pages (from-to)	1582-1593
Number of pages	12
Journal	Molecular Cancer Research
Volume	17
Issue number	7
DOIs	https://doi.org/10.1158/1541-7786.MCR-18-1127
Publication status	Published - 1 Jul 2019

ASJC Scopus subject areas

Molecular Biology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

More information

10.1158/1541-7786.MCR-18-1127

Cite this

Chiu, A. P., Tschida, B. R., Sham, T. T., Lo, L. H., Moriarity, B. S., Li, X. X., Lo, R. C., Hinton, D. E., Rowlands, D. K., Chan, C. O., Mok, D. K. W., Largaespada, D. A., Warner, N., & Keng, V. W. (2019). HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism. Molecular Cancer Research, 17(7), 1582-1593. https://doi.org/10.1158/1541-7786.MCR-18-1127

@article{472fc9d8c1804afa9b3a348e427d54ac,

title = "HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism",

abstract = "Chronic hepatitis B viral (HBV) infection remains a high underlying cause for hepatocellular carcinoma (HCC) worldwide, while the genetic mechanisms behind this remain unclear. This study elucidated the mechanisms contributing to tumor development induced by the HBV X (HBx) gene of predominantly Asian genotype B HBV and its common HBx variants. To compare the potential tumorigenic effects of K130M/V131I (Mut) and wild-type (WT) HBx on HCC, the Sleeping Beauty (SB) transposon system was used to deliver HBx Mut and WT into the livers of fumarylacetoacetate hydrolase (Fah)-deficient mice and in the context of transformation related protein 53 (Trp53) deficiency. From our results, HBx Mut had a stronger tumorigenic effect than its WT variant. Also, inflammation, necrosis, and fibrosis were evident in HBx experimental animals. Reduction of forkhead box O1 (FOXO1) with increased phosphorylation of upstream serine/ threonine kinase (AKT) was detected under HBx Mut overexpression. Thus, it is proposed that HBx Mut enhances disease progression by reducing FOXO1 via phosphorylation of AKT. At the metabolomic level, HBx altered the expression of genes that participated in arachidonic acid (AA) metabolism, as a result of inflammation via accumulation of proinflammatory factors such as prostaglandins and leukotriene in liver. Taken together, the increased rate of HCC observed in chronic hepatitis B patients with K130M/V131I-mutated X protein, may be due to changes in AA metabolism and AKT/ FOXO1 signaling.",

author = "Chiu, {Amy P.} and Tschida, {Barbara R.} and Sham, {Tung Ting} and Lo, {Lilian H.} and Moriarity, {Branden S.} and Li, {Xiao Xiao} and Lo, {Regina C.} and Hinton, {David E.} and Rowlands, {Dewi K.} and Chan, {Chi On} and Mok, {Daniel K.W.} and Largaespada, {David A.} and Nadia Warner and Keng, {Vincent W.}",

year = "2019",

month = jul,

day = "1",

doi = "10.1158/1541-7786.MCR-18-1127",

language = "English",

volume = "17",

pages = "1582--1593",

journal = "Cell Growth and Differentiation",

issn = "1541-7786",

publisher = "American Association for Cancer Research Inc.",

number = "7",

}

Chiu, AP, Tschida, BR, Sham, TT, Lo, LH, Moriarity, BS, Li, XX, Lo, RC, Hinton, DE, Rowlands, DK, Chan, CO, Mok, DKW, Largaespada, DA, Warner, N & Keng, VW 2019, 'HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism', Molecular Cancer Research, vol. 17, no. 7, pp. 1582-1593. https://doi.org/10.1158/1541-7786.MCR-18-1127

TY - JOUR

T1 - HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism

AU - Chiu, Amy P.

AU - Tschida, Barbara R.

AU - Sham, Tung Ting

AU - Lo, Lilian H.

AU - Moriarity, Branden S.

AU - Li, Xiao Xiao

AU - Lo, Regina C.

AU - Hinton, David E.

AU - Rowlands, Dewi K.

AU - Chan, Chi On

AU - Mok, Daniel K.W.

AU - Largaespada, David A.

AU - Warner, Nadia

AU - Keng, Vincent W.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Chronic hepatitis B viral (HBV) infection remains a high underlying cause for hepatocellular carcinoma (HCC) worldwide, while the genetic mechanisms behind this remain unclear. This study elucidated the mechanisms contributing to tumor development induced by the HBV X (HBx) gene of predominantly Asian genotype B HBV and its common HBx variants. To compare the potential tumorigenic effects of K130M/V131I (Mut) and wild-type (WT) HBx on HCC, the Sleeping Beauty (SB) transposon system was used to deliver HBx Mut and WT into the livers of fumarylacetoacetate hydrolase (Fah)-deficient mice and in the context of transformation related protein 53 (Trp53) deficiency. From our results, HBx Mut had a stronger tumorigenic effect than its WT variant. Also, inflammation, necrosis, and fibrosis were evident in HBx experimental animals. Reduction of forkhead box O1 (FOXO1) with increased phosphorylation of upstream serine/ threonine kinase (AKT) was detected under HBx Mut overexpression. Thus, it is proposed that HBx Mut enhances disease progression by reducing FOXO1 via phosphorylation of AKT. At the metabolomic level, HBx altered the expression of genes that participated in arachidonic acid (AA) metabolism, as a result of inflammation via accumulation of proinflammatory factors such as prostaglandins and leukotriene in liver. Taken together, the increased rate of HCC observed in chronic hepatitis B patients with K130M/V131I-mutated X protein, may be due to changes in AA metabolism and AKT/ FOXO1 signaling.

AB - Chronic hepatitis B viral (HBV) infection remains a high underlying cause for hepatocellular carcinoma (HCC) worldwide, while the genetic mechanisms behind this remain unclear. This study elucidated the mechanisms contributing to tumor development induced by the HBV X (HBx) gene of predominantly Asian genotype B HBV and its common HBx variants. To compare the potential tumorigenic effects of K130M/V131I (Mut) and wild-type (WT) HBx on HCC, the Sleeping Beauty (SB) transposon system was used to deliver HBx Mut and WT into the livers of fumarylacetoacetate hydrolase (Fah)-deficient mice and in the context of transformation related protein 53 (Trp53) deficiency. From our results, HBx Mut had a stronger tumorigenic effect than its WT variant. Also, inflammation, necrosis, and fibrosis were evident in HBx experimental animals. Reduction of forkhead box O1 (FOXO1) with increased phosphorylation of upstream serine/ threonine kinase (AKT) was detected under HBx Mut overexpression. Thus, it is proposed that HBx Mut enhances disease progression by reducing FOXO1 via phosphorylation of AKT. At the metabolomic level, HBx altered the expression of genes that participated in arachidonic acid (AA) metabolism, as a result of inflammation via accumulation of proinflammatory factors such as prostaglandins and leukotriene in liver. Taken together, the increased rate of HCC observed in chronic hepatitis B patients with K130M/V131I-mutated X protein, may be due to changes in AA metabolism and AKT/ FOXO1 signaling.

UR - http://www.scopus.com/inward/record.url?scp=85069265253&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-18-1127

DO - 10.1158/1541-7786.MCR-18-1127

M3 - Journal article

C2 - 30975706

AN - SCOPUS:85069265253

SN - 1541-7786

VL - 17

SP - 1582

EP - 1593

JO - Cell Growth and Differentiation

JF - Cell Growth and Differentiation

IS - 7

ER -

HBx-K130M/V131I promotes liver cancer in transgenic mice via AKT/FOXO1 signaling pathway and arachidonic acid metabolism

Abstract

ASJC Scopus subject areas

UN SDGs

More information

Other files and links

Fingerprint

Cite this